期刊文献+

VEGF反义寡核苷酸抑制荷瘤大鼠胶质瘤血管生成的作用和效果 被引量:2

INHIBITORY EFFECT ON ANGIOGENESIS AND GLIOMA GROWTH OF TUMOR-BEARING RATS OF VEGF ANTISENSE OLIGONUCLEOTIDE
下载PDF
导出
摘要 观察在荷瘤大鼠脑内原位注射血管内皮生长因子(VEGF)反义寡核苷酸对胶质瘤的血管生成的抑制效果。所有大鼠均在立体定向导引下右尾状核区接种含C6胶质瘤细胞 1× 10 6的Hank液 (2 0 μl)。实验Ⅰ和Ⅱ组在细胞接种后的 1和 2周各原位注射 1次 ,共 2次 ,每次实验Ⅰ组为 10 0 0 μmol/L、实验Ⅱ组为2 0 0 0 μmol/L的VEGF反义寡苷核酸。对照组仅在接种后第 1和 2周原位注射 2 0 μl的Hank液。第 3周时处死所有大鼠 ,观察肿瘤的生长情况 ,标本做常规HE染色和免疫组化染色检查VEGF的表达和血管密度 (MVD) ;原位杂交观察VEGFmRNA的表达。结果显示 ,实验组大鼠有较好的生存状态 ,而对照组在实验 2周时开始出现颅内高压症状 ,至 3周时大鼠大多处于濒危状态 ;成瘤抑制率实验Ⅰ组为 91 5 % ,实验Ⅱ组为 10 0 % ;实验组和对照组VEGFmRNA、VEGF的表达和微血管密度比较差异有显著性意义。研究表明 。 To observe the inhibitory effects of VEGF antisense oligonuoleotide on angiogenesis and glioma growth of tumor bearing rats. 1×10 6 C 6 glioma cells(20μl) were seeded with high flow microinfusion into right caudate nucleus of all rats with sterotactic technique. In the treatment groups Ⅰ and Ⅱ 1 000 μmol/L, 2 000 μmol/L VEGF antisense oligonucleotide was respectively given at the site of seeding twice 1 and 2 weeks after cell inoculation. The control group received only 20μl Hank′s solution twicely. Three weeks after cell inoculation, the general condition of the treated rats were better, while rats in control group were in precarious conditions. The inhibition rate of tumor growth was 91 5% in the treated group Ⅰ, 100% in the treated group Ⅱ. The expressions of VEGF mRNA, VEGF, and MVD were significantly different between treatment and control groups. The results indicated that VEGF was required for the maintenance of angiogenesis in the tumor, and inhibition of VEGF might be a therepeutic strategy in the treatment of glioma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2003年第2期144-145,T001,共3页 Medical Journal of Chinese People's Liberation Army
基金 上海市优秀学科带头人资助计划基金资助课题(编号 99XD1 4 0 0 2 )
关键词 反义寡核苷酸 胶质瘤 血管内皮生长因子 抑制 大鼠 oligonucleotide, antisense glioma vascular endothelial growth factor inhibition rats
  • 相关文献

参考文献4

  • 1[1]Morreale VM, Herman BH, Der-Minassian V et al. A brain-tumor model utilizing implantation of a permanent Cannula. J Neurosurg,1993,78:959
  • 2[2]Weinder N. Intratumor micro-vessel density as prognostic factor in cancer. AmJ Path, 1995,147:9
  • 3[3]Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor(VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA, 1997,94:8761
  • 4[4]Folkman J,Ingber D. Inhibition of angiogenesis. Sem Cancer Biol, 1992,3:89

同被引文献18

  • 1王晨.脑胶质瘤的临床治疗[J].医学信息(医学与计算机应用),2014,0(10):500-500. 被引量:1
  • 2王煜,牛洪泉,董芳永,董震,柳再明,雷霆,薛德麟.大鼠树突状细胞疫苗治疗脑胶质瘤的实验研究[J].中国临床神经外科杂志,2005,10(2):115-117. 被引量:12
  • 3石键,赵洪洋,谭正.大鼠脑胶质瘤模型建立与生长评估[J].中国临床神经外科杂志,2006,11(2):98-100. 被引量:5
  • 4Weiss WA, Burns MJ, Hackett C, et al. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res, 2003; 63 (7): 1589-1595
  • 5Watanabe K, Sakamoto M, somiya M, et al. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region. Neurol Res, 2002 Jul, 24(5): 485-490
  • 6Zhang Y , Wang Y, Zhang Y, et al. C6 glioma cells retrovirally engineered to express IL-18 and Fas exert FasL-dependent cytotoxicity against glioma formation.Biochem Biophys Res Commun, 2004, 325 (4): 1240-1245
  • 7Li Y, Owusu A, Lehnert S. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy. Int J Radiat Oncol Biol Phys, 2004, 58 (2): 519-527
  • 8Vince GH, Bendszus M, Spontaneous regression of experimental gliom as-an irnmunoh is tochemical and MRI study of the C6 glioma spheroid implantation model. J Experimental Neurology, 2004, 190:478-485
  • 9高斌,贺克武,李嘉嘉.剪碎法及匀浆法制备兔肌肉VX2肿瘤单细胞悬液的方法比较[J].中国组织工程研究与临床康复,2007,11(41):8315-8317. 被引量:7
  • 10Watanabe K, Sakamoto M, Somiya M, et al. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region [J]. Neurol Res, 2002, 24(5) : 485 -490.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部